CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...